Publications of Tobias Derfuss
All genres
Journal Article (22)
1.
Journal Article
79 (23), pp. 2241 - 2248 (2012)
Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 2.
Journal Article
8 (11), pp. 613 - 623 (2012)
B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nature Reviews Neurology 3.
Journal Article
85 (19), pp. 9680 - 9685 (2011)
Expression of herpes simplex virus 1-encoded microRNAs in human trigeminal ganglia and their relation to local T-cell infiltrates. Journal of Virology 4.
Journal Article
306 (1-2), pp. 180 - 182 (2011)
Humoral autoimmunity in multiple sclerosis. Journal of the Neurological Sciences 5.
Journal Article
77 (6), pp. 580 - 588 (2011)
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 6.
Journal Article
88 (8), pp. 753 - 761 (2010)
Axo-glial antigens as targets in multiple sclerosis: Implications for axonal and grey matter injury. Journal of Molecular Medicine 7.
Journal Article
1 (2), pp. 47 - 60 (2010)
Identifying targets for autoantibodies in CNS inflammation: Strategies and achievements. Clinical and Experimental Neuroimmunology 8.
Journal Article
106 (20), pp. 8302 - 8307 (2009)
Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proceedings of the National Academy of Sciences of the United States of America 9.
Journal Article
274 (1-2), pp. 42 - 44 (2008)
Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis. Journal of Neurological Sciences 10.
Journal Article
131, pp. 1455 - 1463 (2008)
Interferon-β increases BAFF levels in multiple sclerosis: Implications for B cell autoimmunity. Brain 11.
Journal Article
35 (7), pp. 345 - 355 (2008)
Autoantigen- und erregerspezifische T- und B-Zellreaktionen bei multipler Sklerose: „Eine unendliche Geschichte”? Aktuelle Neurologie 12.
Journal Article
204 (1-2), pp. 92 - 100 (2008)
Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 13.
Journal Article
17 (4), pp. 389 - 398 (2007)
Presence of HSV-1 immediate early genes and clonally expanded T-cells with a memory effector phenotype in human trigeminal ganglia. Brain Pathology 14.
Journal Article
13 (5), pp. 462 - 467 (2007)
The prevalence of human herpesvirus 6 in human sensory ganglia and its co-occurrence with alpha-herpesvirus. Journal of Neurovirology 15.
Journal Article
190 (1-2), pp. 72 - 79 (2007)
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. Journal of Neuroimmunology 16.
Journal Article
204 (10), pp. 2363 - 2372 (2007)
Neurofascin as a novel target for autoantibody-mediated axonal injury. Journal of Experimental Medicine 17.
Journal Article
129, pp. 200 - 211 (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 18.
Journal Article
175 (4), pp. 2301 - 2308 (2005)
Expression and function of glial cell line-derived neurotrophic factor (GDNF) family ligands and their receptors on human immune cells. Journal of Immunology 19.
Journal Article
252 (8), pp. 968 - 971 (2005)
Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. Journal of Neurology 20.
Journal Article
201 (2), pp. 195 - 200 (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. Journal of Experimental Medicine